Literature DB >> 16484693

Increasing trial generalizability.

Carolyn C Gotay1.   

Abstract

Mesh：

Year:  2006        PMID： 16484693     DOI： 10.1200/JCO.2005.04.5120

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Estimation of Population Average Treatment Effects in the FIRST Trial: Application of a Propensity Score-Based Stratification Approach.

Authors:  Jeanette W Chung; Karl Y Bilimoria; Jonah J Stulberg; Christopher M Quinn; Larry V Hedges
Journal:  Health Serv Res       Date:  2017-08-21       Impact factor: 3.402

2.  Contraindicated use of bevacizumab and toxicity in elderly patients with cancer.

Authors:  Dawn L Hershman; Jason D Wright; Emerson Lim; Donna L Buono; Wei Yann Tsai; Alfred I Neugut
Journal:  J Clin Oncol       Date:  2013-09-03       Impact factor: 44.544

3.  Using an automated recruitment process to generate an unbiased study sample of multiple sclerosis patients.

Authors:  Deborah M Miller; R Fox; A Atreja; S Moore; J-C Lee; A Z Fu; A Jain; W Saupe; S Chakraborty; M Stadtler; R A Rudick
Journal:  Telemed J E Health       Date:  2010 Jan-Feb       Impact factor: 3.536

4.  Assessing the Validity of a a priori Patient-Trial Generalizability Score using Real-world Data from a Large Clinical Data Research Network: A Colorectal Cancer Clinical Trial Case Study.

Authors:  Qian Li; Zhe He; Yi Guo; Hansi Zhang; Thomas J George; William Hogan; Neil Charness; Jiang Bian
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.